688029 南微医学
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额106,403687,946613,022545,575250,139
投资活动产生之现金流量净额(381,300)(925,010)412,368(1,137,365)668,589
筹资活动产生之现金流量净额(189,823)(203,828)(357,481)(114,494)(73,758)
汇率变动对现金及现金等价物的影响(41,619)7,353(6,955)40,18762,930
现金及现金等价物净增加/(减少)(506,339)(433,540)660,953(666,098)907,900
期初现金及现金等价物余额1,436,6761,870,2161,209,2631,875,361967,461
期末现金及现金等价物余额930,3371,436,6761,870,2161,209,2631,875,361